{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T03:25:26Z","timestamp":1792725926750,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100018551","name":"Science and Technology Innovation Talents in Universities of Henan Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018551","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.intimp.2024.112799","type":"journal-article","created":{"date-parts":[[2024,7,27]],"date-time":"2024-07-27T12:04:24Z","timestamp":1722081864000},"page":"112799","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Farnesoid\u00a0X\u00a0Receptor: Effective alleviation of rifampicin -induced liver injury"],"prefix":"10.1016","volume":"139","author":[{"given":"Yun","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meijie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutong","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihua","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longmei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yandong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3386-4492","authenticated-orcid":false,"given":"Wei-Dong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2024.112799_b0005","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/j.ijid.2021.02.107","article-title":"Global Tuberculosis Report 2020 - Reflections on the Global TB burden, treatment and prevention efforts","volume":"113 Suppl 1(Suppl 1)","author":"Chakaya","year":"2021","journal-title":"Int. J. Infect. Dis."},{"issue":"6","key":"10.1016\/j.intimp.2024.112799_b0010","article-title":"The Potential Role of Metabolomics in Drug-Induced Liver Injury (DILI)","volume":"12","author":"Moreno-Torres","year":"2022","journal-title":"Assessment. Metabolites"},{"issue":"8","key":"10.1016\/j.intimp.2024.112799_b0015","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1053\/j.gastro.2019.02.002","article-title":"Incidence and Etiology of Drug-Induced Liver Injury in Mainland China","volume":"156","author":"Shen","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.intimp.2024.112799_b0020","doi-asserted-by":"crossref","first-page":"8086253","DOI":"10.1155\/2021\/8086253","article-title":"Antituberculosis Drugs (Rifampicin and Isoniazid) Induce Liver Injury by Regulating NLRP3 Inflammasomes","volume":"2021","author":"Su","year":"2021","journal-title":"Mediators Inflamm."},{"issue":"2","key":"10.1016\/j.intimp.2024.112799_b0025","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1440-1746.2007.05207.x","article-title":"Antituberculosis drug-induced hepatotoxicity: concise up-to-date review","volume":"23","author":"Tostmann","year":"2008","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"7855","key":"10.1016\/j.intimp.2024.112799_b0030","first-page":"421","article-title":"Rifampicin hepatitis","volume":"1","author":"Scheuer","year":"1974","journal-title":"A Clinical and Histological Study. Lancet"},{"key":"10.1016\/j.intimp.2024.112799_b0035","doi-asserted-by":"crossref","unstructured":"Chalasani N, Fontana RJ, Bonkovsky HL, Watkins PB, Davern T, Serrano J, Yang H, Rochon J: Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States. Gastroenterology 2008, 135(6):1924-1934, 1934.e1921-1924.","DOI":"10.1053\/j.gastro.2008.09.011"},{"issue":"1","key":"10.1016\/j.intimp.2024.112799_b0040","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s13578-023-01035-1","article-title":"Bile acid-mediated signaling in cholestatic liver diseases","volume":"13","author":"Zeng","year":"2023","journal-title":"Cell Biosci."},{"issue":"9","key":"10.1016\/j.intimp.2024.112799_b0045","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.1007\/s00204-020-02804-4","article-title":"In vitro assessment of farnesoid X receptor antagonism to predict drug-induced liver injury risk","volume":"94","author":"Norona","year":"2020","journal-title":"Arch. Toxicol."},{"issue":"2","key":"10.1016\/j.intimp.2024.112799_b0050","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/toxsci\/kfx091","article-title":"Troglitazone Inhibits Bile Acid Amidation: A Possible Risk Factor for Liver Injury","volume":"158","author":"Ogimura","year":"2017","journal-title":"Toxicol. Sci."},{"issue":"9","key":"10.1016\/j.intimp.2024.112799_b0055","doi-asserted-by":"crossref","first-page":"4025","DOI":"10.1210\/en.2005-1485","article-title":"The nuclear hormone receptor farnesoid X receptor (FXR) is activated by androsterone","volume":"147","author":"Wang","year":"2006","journal-title":"Endocrinology"},{"key":"10.1016\/j.intimp.2024.112799_b0060","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.729828","article-title":"Post-Translational Modifications of FXR; Implications for Cholestasis and Obesity-Related Disorders","volume":"12","author":"Appelman","year":"2021","journal-title":"Front Endocrinol (lausanne)"},{"key":"10.1016\/j.intimp.2024.112799_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2022.111618","article-title":"Discovery of farnesoid X receptor and its role in bile acid metabolism","volume":"548","author":"Chiang","year":"2022","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.intimp.2024.112799_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2019.110916","article-title":"Alteration of mitochondrial DNA homeostasis in drug-induced liver injury","volume":"135","author":"Fromenty","year":"2020","journal-title":"Food Chem. Toxicol."},{"issue":"6","key":"10.1016\/j.intimp.2024.112799_b0085","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.clinre.2012.06.006","article-title":"The bile salt export pump (BSEP) in health and disease","volume":"36","author":"Kubitz","year":"2012","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"issue":"3","key":"10.1016\/j.intimp.2024.112799_b0090","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/jac\/33.3.387","article-title":"Hepatic side-effects of antibiotics","volume":"33","author":"Westphal","year":"1994","journal-title":"J. Antimicrob. Chemother."},{"issue":"2","key":"10.1016\/j.intimp.2024.112799_b0095","doi-asserted-by":"crossref","first-page":"11700","DOI":"10.1080\/21655979.2021.2003930","article-title":"Study on the associations between liver damage and antituberculosis drug rifampicin and relative metabolic enzyme gene polymorphisms","volume":"12","author":"Su","year":"2021","journal-title":"Bioengineered"},{"issue":"3","key":"10.1016\/j.intimp.2024.112799_b0100","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1002\/cphy.c120023","article-title":"Bile acid metabolism and signaling","volume":"3","author":"Chiang","year":"2013","journal-title":"Compr. Physiol."},{"issue":"2","key":"10.1016\/j.intimp.2024.112799_b0105","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1152\/physrev.00027.2002","article-title":"Bile salt transporters: molecular characterization, function, and regulation","volume":"83","author":"Trauner","year":"2003","journal-title":"Physiol. Rev."},{"issue":"2","key":"10.1016\/j.intimp.2024.112799_b0110","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1093\/toxsci\/kfx094","article-title":"Editor's Highlight: Farnesoid X Receptor Protects Against Low-Dose Carbon Tetrachloride-Induced Liver Injury Through the Taurocholate-JNK Pathway","volume":"158","author":"Takahashi","year":"2017","journal-title":"Toxicol. Sci."},{"issue":"Suppl 1","key":"10.1016\/j.intimp.2024.112799_b0115","first-page":"S10","article-title":"Bile salt excretory pump: biology and pathobiology","volume":"43","author":"Suchy","year":"2006","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"issue":"3","key":"10.1016\/j.intimp.2024.112799_b0120","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.jhep.2005.05.020","article-title":"Impaired expression and function of the bile salt export pump due to three novel ABCB11 mutations in intrahepatic cholestasis","volume":"43","author":"Noe","year":"2005","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.intimp.2024.112799_b0125","doi-asserted-by":"crossref","first-page":"201","DOI":"10.5223\/pghn.2019.22.2.201","article-title":"Benign Recurrent Intrahepatic Cholestasis Type 2 in Siblings with Novel ABCB11 Mutations","volume":"22","author":"Sohn","year":"2019","journal-title":"Pediatr Gastroenterol Hepatol Nutr"},{"issue":"3","key":"10.1016\/j.intimp.2024.112799_b0130","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1053\/jhep.2001.22646","article-title":"Hepatobiliary transporter expression in percutaneous liver biopsies of patients with cholestatic liver diseases","volume":"33","author":"Zollner","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.intimp.2024.112799_b0135","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.tiv.2017.10.012","article-title":"Kinetic characterization of bile salt transport by human NTCP (SLC10A1)","volume":"46","author":"Jani","year":"2018","journal-title":"Toxicol. In Vitro"},{"issue":"5","key":"10.1016\/j.intimp.2024.112799_b0140","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1007\/s00424-003-1130-z","article-title":"The sodium bile salt cotransport family SLC10","volume":"447","author":"Hagenbuch","year":"2004","journal-title":"Pflugers Arch."},{"issue":"1\u20132","key":"10.1016\/j.intimp.2024.112799_b0145","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.mce.2012.05.004","article-title":"FXR signaling in the enterohepatic system","volume":"368","author":"Matsubara","year":"2013","journal-title":"Mol. Cell. Endocrinol."},{"issue":"8","key":"10.1016\/j.intimp.2024.112799_b0150","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nrc2694","article-title":"Signal integration by JNK and p38 MAPK pathways in cancer development","volume":"9","author":"Wagner","year":"2009","journal-title":"Nat. Rev. Cancer"},{"issue":"28","key":"10.1016\/j.intimp.2024.112799_b0155","doi-asserted-by":"crossref","first-page":"16492","DOI":"10.1073\/pnas.2002672117","article-title":"JNK-mediated disruption of bile acid homeostasis promotes intrahepatic cholangiocarcinoma","volume":"117","author":"Manieri","year":"2020","journal-title":"PNAS"},{"key":"10.1016\/j.intimp.2024.112799_b0160","article-title":"Scoparone Improves Nonalcoholic Steatohepatitis Through Alleviating JNK\/Sab Signaling Pathway-Mediated Mitochondrial Dysfunction","volume":"13","author":"Jiang","year":"2022","journal-title":"Front. Pharmacol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924013201?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924013201?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T08:09:21Z","timestamp":1732954161000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924013201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":30,"alternative-id":["S1567576924013201"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.112799","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Farnesoid\u00a0X\u00a0Receptor: Effective alleviation of rifampicin -induced liver injury","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.112799","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112799"}}